Niederhofer H
Child and Adolescent Psychiatry, Regional Hospital Bozen, Via Guncina 54/A, 39100 Bolzano, Italy.
Phytomedicine. 2009 Apr;16(4):284-6. doi: 10.1016/j.phymed.2008.10.006. Epub 2008 Dec 20.
Noradrenaline and serotonin reuptake inhibitors have been proven to be effective in some cases of ADHD. In this open trial, Matricaria chamomilla, a serotonin and noradrealine reuptake inhibitor, actually used as an antidepressant, has been checked for this indication.
Three 14-16-year-old male psychiatric outpatients, diagnosed with attention-deficit disorder (ADHD) have been rated at baseline and while taking Matricaria chamomilla to determine its efficacy as a treatment for ADHD. Improvement was valuated using comparisons of Conners' parent ratings.
Patients' mean scores improved for Conners' hyperactivity, inattention and immaturity factors.
Although the sample size is very small and therefore generalization is very difficult, this observation indicates that Matricaria chamomilla might be a slightly effective treatment also for ADHD.
去甲肾上腺素和5-羟色胺再摄取抑制剂已被证实在某些多动症病例中有效。在这项开放性试验中,对洋甘菊(一种5-羟色胺和去甲肾上腺素再摄取抑制剂,实际用作抗抑郁药)针对该适应症进行了检验。
三名年龄在14 - 16岁、被诊断患有注意力缺陷障碍(多动症)的男性精神科门诊患者,在基线时以及服用洋甘菊期间接受评估,以确定其作为多动症治疗方法的疗效。使用康纳斯父母评定量表进行比较来评估改善情况。
患者在康纳斯多动、注意力不集中和不成熟因子方面的平均得分有所改善。
尽管样本量非常小,因此很难进行推广,但这一观察结果表明,洋甘菊可能对多动症也有一定疗效。